Jim Simons Invitae Corp Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.72 $923,033 - $1.58 Million	2,197,698 New	2,197,698 $1.38 Million
Q2 2023 Aug 11, 2023	BUY	$1.05 - $1.63 $1.99 Million - $3.09 Million	1,896,600 Added 1574.18%	2,017,082 $2.28 Million
Q1 2023 May 12, 2023	BUY	$1.2 - $2.73 $144,578 - $328,915	120,482 New	120,482 $163,000
Q2 2022 Aug 12, 2022	BUY	$2.13 - $9.01 $653,986 - $2.77 Million	307,036 Added 29.56%	1,345,818 $3.28 Million
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $6.52 Million - $16.2 Million	1,038,782 New	1,038,782 $8.28 Million

Q3 2019 Nov 13, 2019	SELL	$18.85 - $27.5 $7.06 Million - $10.3 Million	-374,382 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$17.37 - $26.27 $2.09 Million - $3.16 Million	-120,171 Reduced 24.3%	374,382 $8.8 Million
Q1 2019 May 14, 2019	BUY	$10.65 - $25.75 $298,956 - $722,828	28,071 Added 6.02%	494,553 $11.6 Million
Q4 2018 Feb 13, 2019	BUY	$9.26 - $16.38 $4.32 Million - $7.64 Million	466,482 New	466,482 $5.16 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.